By week 48 (approximately one year), participants lost more than 24% of their starting weightan average of about 58 pounds.[4] This level of weight loss appears greater than what has been observed in studies of medications like Wegovy or Ozempic.[6,7] Additionally, nearly all 338 participants who took lower doses of retatrutide experienced weight reductions between 5% and 15%.[4] Even modest weight loss can have meaningful health benefits
Adverse reactions to drugs | Medicines guidance | BNF | NICE
People with inflammatory arthritis often have comorbidities, including heart disease, renal insufficiency, and diabetes, says Dr
Glucagon-like peptide-1 (GLP-1) encourages the pancreas to release the right amount of insulin, slowing the bodys digestive rhythm, reducing appetite, and stabilizing blood sugar, all of which power the accomplishment of your medically-supported wellness goals without the expense of surgery or other invasive treatments
These compounds directly stimulate L-cells to release GLP-1
These changes, as an almost general rule, include improved endothelial function, reduction of inflammatory markers, oxidative stress ischemia/reperfusion injury and atherogenesis